A Tweak to Immune Cells Reverses Aging in Mice
A Tweak to Immune Cells Reverses Aging in Mice
Knocking out the receptor for a lipid that causes inflammation rejuvenates macrophage metabolism and restores cognitive function in an Alzheimer’s disease model.
A Tweak to Immune Cells Reverses Aging in Mice
A Tweak to Immune Cells Reverses Aging in Mice

Knocking out the receptor for a lipid that causes inflammation rejuvenates macrophage metabolism and restores cognitive function in an Alzheimer’s disease model.

Knocking out the receptor for a lipid that causes inflammation rejuvenates macrophage metabolism and restores cognitive function in an Alzheimer’s disease model.

inflammation
The Brain on COVID-19
The Brain on COVID-19
The Scientist Creative Services Team | Dec 21, 2020
Connecting the dots between COVID-19 and neurological disorders
Beyond Acute Respiration: SARS-CoV-2's Effects on Long-Term Physiology
Beyond Acute Respiration: SARS-CoV-2's Effects on Long-Term Physiology
The Scientist Creative Services Team | Nov 11, 2020
John Connolly and Masataka Nishiga discuss the effects of SARS-CoV-2 on the neurological and cardiovascular systems.
First Responders: SARS-CoV-2 and the Immune System
First Responders: SARS-CoV-2 and the Immune System
The Scientist Creative Services Team | Oct 29, 2020
Angela Rasmussen and Ya-Chi Ho explore the positive and negative aspects of the host immune response to SARS-CoV-2 infection and discuss how this knowledge influences therapeutic benefits.
Breaking Down Barriers
Breaking Down Barriers
The Scientist Creative Services Team | Oct 19, 2020
Looking at the future of neurodegeneration research!
Study Points to Novel Role for Microglia in Down Syndrome
Study Points to Novel Role for Microglia in Down Syndrome
Catherine Offord | Oct 6, 2020
Overactive immune cells identified in a mouse model and in postmortem human brain tissue may offer a potential therapeutic target for cognitive delays associated with the condition, researchers report.
Kids’ Severe COVID-19 Reaction Bears Unique Immune Signature
Kids’ Severe COVID-19 Reaction Bears Unique Immune Signature
Shawna Williams | Sep 29, 2020
The rare complication known as multisystem inflammatory syndrome in children (MIS-C) differs from both Kawasaki disease and severe adult cases of COVID-19, a study finds.
Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
Catherine Offord | Sep 3, 2020
A meta-analysis of seven randomized controlled trials concludes that dexamethasone and other corticosteroids reduce 28-day mortality in seriously ill patients.
Could COVID-19 Trigger Chronic Disease in Some People?
Could COVID-19 Trigger Chronic Disease in Some People?
Katarina Zimmer | Jul 17, 2020
A handful of viruses have been associated with long-term, debilitating symptoms in a subset of those who become infected. Early signs hint that SARS-CoV-2 may do the same.
Identified: Molecular Predictors of Rheumatoid Arthritis Relapse
Identified: Molecular Predictors of Rheumatoid Arthritis Relapse
Ruth Williams | Jul 15, 2020
The presence of a particular set of RNAs in the blood forewarns of an onset of severe symptoms and points to the cells involved.